search
Back to results

Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (STOP-OP)

Primary Purpose

Bladder Cancer, Smoking, Alcohol Consumption

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Educational programme for smoking and alcohol cessation
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Bladder Cancer focused on measuring Radical cystectomy, Bladder cancer, Smoking cessation, Alcohol cessation, Postoperative complications

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients > 18 years scheduled for cystectomy due to bladder cancer
  • Daily smoker or/and intake of

    ->21 units (252 g) of alcohol pr week

  • Informed consent

Exclusion Criteria:

  • Cancelled operation
  • Hypersensitivity to benzodiazepines, disulfiram or Nicotine replacement
  • Pregnant or breastfeeding women
  • Mentally incompetent patients

Sites / Locations

  • Department of Urology, University Hospital of Copenhagen

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Smoking and alcohol cessation education

Standard treatment

Arm Description

Standard treatment is information about benefits of stopping drinking and smoking before surgery and if wanted, advice about who to contact to get support.

Outcomes

Primary Outcome Measures

Number of patients with postoperative complications
Both number of patients with postoperative complications and number of postoperative complications according to the Clavien Dindo classification will be measured

Secondary Outcome Measures

Postoperative complications
Smoking and alcohol cessation up to 12 months postoperatively Smoking and alcohol cessation
Length of stay
Time to return to work or habitual level of activity
Mortality
Quality of life ( EORTC QLQ BLM 30 and EQ5D)

Full Information

First Posted
May 28, 2014
Last Updated
January 31, 2019
Sponsor
Rigshospitalet, Denmark
Collaborators
Frederiksberg University Hospital, Aalborg University Hospital, Copenhagen University Hospital at Herlev, Odense University Hospital, Aarhus University Hospital, Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT02188446
Brief Title
Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients
Acronym
STOP-OP
Official Title
Randomised Controlled Multicenter Study.Effect of an Intensive Smoking- and/or Alcohol Cessation Intervention Placed Shortly Before and 5 Weeks After Bladder Cancer Surgery on Postoperative Complications
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
November 2014 (Actual)
Primary Completion Date
July 2018 (Actual)
Study Completion Date
July 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
Collaborators
Frederiksberg University Hospital, Aalborg University Hospital, Copenhagen University Hospital at Herlev, Odense University Hospital, Aarhus University Hospital, Karolinska Institutet

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Radical cystectomy provides the best cancer-specific survival for muscle-invasive urothelial cancer. However the postoperative morbidity remains at 11-68 %. Smoking and alcohol consumption above two drinks per day is associated with an increased risk of postoperative morbidity. Six-eight weeks of smoking and alcohol abstinence prior to elective surgery is recommended to reduce this risk, but for cancer patients the preoperative period is often very short. This randomised clinical trial (STOP-OP) will reach a conclusion on the effect of a new Gold Standard Programme for both smoking and alcohol cessation Intervention using the Gold Standard Programme (GSP) on the frequency and severity of postoperative complications after bladder cancer surgery.
Detailed Description
The study is a multicentre randomised clinical trial involving 110 patients with a risky alcohol intake (exceeding 21 alcohol units (252 g ethanol) per week or/ and daily smoking scheduled for bladder cancer surgery. Patients will be randomised to the 6-weeks GSP or treatment as usual (control). The GSP combines patient education and pharmacologic strategies. The GSP includes benzodiazepine therapy for withdrawal symptoms, controlled disulfiram therapy, and Nicotine replacement.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer, Smoking, Alcohol Consumption
Keywords
Radical cystectomy, Bladder cancer, Smoking cessation, Alcohol cessation, Postoperative complications

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
105 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Smoking and alcohol cessation education
Arm Type
Experimental
Arm Title
Standard treatment
Arm Type
No Intervention
Arm Description
Standard treatment is information about benefits of stopping drinking and smoking before surgery and if wanted, advice about who to contact to get support.
Intervention Type
Behavioral
Intervention Name(s)
Educational programme for smoking and alcohol cessation
Other Intervention Name(s)
GSP
Intervention Description
5 meetings within 6 weeks containing education and pharmacologic support
Primary Outcome Measure Information:
Title
Number of patients with postoperative complications
Description
Both number of patients with postoperative complications and number of postoperative complications according to the Clavien Dindo classification will be measured
Time Frame
Up to 6 weeks
Secondary Outcome Measure Information:
Title
Postoperative complications
Time Frame
up to 90 days
Title
Smoking and alcohol cessation up to 12 months postoperatively Smoking and alcohol cessation
Time Frame
Up to 12 months postoperatively
Title
Length of stay
Time Frame
From day of surgery to day of discharge
Title
Time to return to work or habitual level of activity
Time Frame
Up to 12 months
Title
Mortality
Time Frame
Up to 12 months postoperatively
Title
Quality of life ( EORTC QLQ BLM 30 and EQ5D)
Time Frame
Up to 12 months postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients > 18 years scheduled for cystectomy due to bladder cancer Daily smoker or/and intake of ->21 units (252 g) of alcohol pr week Informed consent Exclusion Criteria: Cancelled operation Hypersensitivity to benzodiazepines, disulfiram or Nicotine replacement Pregnant or breastfeeding women Mentally incompetent patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hanne Tønnesen, Professor
Organizational Affiliation
WHO-CC, Clinical Health Promotion Centre, Bispebjerg/Frederiksberg University Hospital, DK 2000 Frederiksberg, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Urology, University Hospital of Copenhagen
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
33422365
Citation
Merzaai B, Tonnesen H, Rasmussen M, Lauridsen SV. Perioperative Alcohol and Smoking Cessation Intervention: Impact on Other Lifestyles. Semin Oncol Nurs. 2021 Feb;37(1):151116. doi: 10.1016/j.soncn.2020.151116. Epub 2021 Jan 6.
Results Reference
derived
PubMed Identifier
28716147
Citation
Lauridsen SV, Thomsen T, Thind P, Tonnesen H. STOP smoking and alcohol drinking before OPeration for bladder cancer (the STOP-OP study), perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial. Trials. 2017 Jul 17;18(1):329. doi: 10.1186/s13063-017-2065-6.
Results Reference
derived
Links:
URL
http://ducg.dk/dablaca-blaerecancer/forskningsprojekter/
Description
DaBlaCa study number 6

Learn more about this trial

Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients

We'll reach out to this number within 24 hrs